Home Antheia

Antheia

In operation
Series C
Small Molecule Drug Developer
Basic
Enterprise Profile
LinkedIn

Basic Information

Antheia is a synthetic biology company that provides next-generation plant-based small molecule drugs, focusing on multiple categories of plant-based drugs that cannot be produced at scale through synthetic chemical processes. Through pioneering whole-cell bioengineering technology, Antheia effectively produces these highly complex drugs by reconstructing unprecedentedly intricate multi-step biosynthetic pathways within yeast cells. With Antheia's technology, we can express dozens of enzymes and transport proteins in cells, transforming them into micro-factories to efficiently construct some of the most complex molecules known to humanity.
Antheia, Inc.
California,United States of America
15~50 people
January 01, 2015
info@antheia.bio

Enterprise Profile

Industrial Sector
Biomanufacturing Compound Discovery New Drug Development Manufacture of Chemical Pharmaceutical Preparations
Technology
Synthetic Biology
Concept
Disease Treatment Department of Pharmacy
Application Scenarios
Chemical Drug Innovative Drugs